BIOA
BioAge Labs, Inc.
BioAge Labs, Inc. (BIOA) has 6 SEC Form 4 filings (21 transaction rows) in the rolling window, disclosed by 2 distinct insiders. Most recent filing: Jul 1, 2026.
The most active filer is Chief Medical Officer RUBIN PAUL D with 3 filings. Insiders have net sold $2.0M over the trailing 6 months.
- Industry:Biotechnology
- CEO:Kristen Fortney
- Employees:62
- HQ:Emeryville, CA, US
- IPO:2024-09-26
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$2.0M
reported sales (SEC code S)
Unique Insiders
2
in the rolling window
Market Cap
$501.0M
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
Barton ShaneFirst filing | Principal Accounting Officer | Sale | 42,350 | $1.1M | Jul 1 | SEC ↗ |
Barton ShaneFirst filing | Principal Accounting Officer | Sale | 20,216 | $509K | Jul 1 | SEC ↗ |
| Chief Medical Officer | Sale | 8,820 | $157K | Apr 3 | SEC ↗ | |
| Chief Medical Officer | Sale | 7,433 | $151K | Mar 3 | SEC ↗ | |
RUBIN PAUL DFirst filing | Chief Medical Officer | Sale | 7,433 | $139K | Feb 3 | SEC ↗ |
Related companies
BioAge Labs, Inc. is in the Healthcare sector.